Related Experiment Video
Updated: Jan 27, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
[miRNA-96-5p inhibits the proliferation and migration of gastric cancer cells by targeting FoxQ1]
1Department of Pharmacy, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Abstract:
Objective: To investigate the role of microRNA-96-5p in the proliferation and invasion of gastric cancer cells and its molecular mechanism. Methods: From June 2015 to January 2017, 53 resected specimens were collected. The transcriptional levels of microRNA-96-5p and forkhead box Q1 (FoxQ1) in gastric cancer tissues and the matched para-cancerous tissues were quantified by quantitative real-time PCR (qRT-PCR). The expression of FoxQ1 protein was also detected by immunohistochemistry (IHC). The relationship between microRNA-96-5p expression and the clinicopathological features of gastric cancer and its correlation with FoxQ1 expression were analyzed. The expressions of miRNA-96-5p in gastric cancer tissue and adjacent normal tissue were detected by qRT-PCR. miRNA-96-5p mimics was transfected to BGC-823 gastric cancer cells. The effects of miRNA-96-5p on cell proliferation and invasion were detected by cell counting kit-8 (CCK-8) assay and Transwell assay, respectively. The protein expressions of FoxQ1, E-cadherin and vimentin were determined by western blot. The relationship between FoxQ1 and miRNA-96-5p expressed in BGC-823 cells was detected by dual-luciferase reporter assay. Results: The median expression of miRNA-96-5p in gastric cancer tissue was 1.05, significantly lower than 3.23 of para-cancerous tissues (P<0.05). The positive rate of FoxQ1 expression in gastric cancer tissue was 71.7%, significantly higher than 28.3% of para-cancerous tissues (P<0.05). The expression of FoxQ1 was negatively corelated with the level of miRNA-96-5p (r=-0.613, P=0.006). The expression of miRNA-96-5p in gastric cancer cell BGC-823 was significantly decreased compared with normal gastric epithelial cell (0.96±0.08 vs 2.84±0.15, P<0.05). The results of CCK-8 assay and Transwell assay showed that overexpression of miRNA-96-5p significantly reduced the proliferation and invasion abilities of gastric cancer cells (P<0.05). Overexpression of miRNA-96-5p decreased the protein level of FoxQ1. Moreover, it upregulated the expression of E-cadherin and downregulated the expression of vimentin. The result of dual-luciferase-3'-UTR reporter assay confirmed that miRNA-96-5p binds to the 3'UTR of FoxQ1. Conclusion: miRNA-96-5p may suppress the proliferation, migration and epithelial-mesenchymal transition (EMT) of gastric cancer cell by down-regulation of FoxQ1.
Insights
MicroRNA-96-5p is downregulated in gastric cancer and suppresses tumor growth. Its overexpression inhibits gastric cancer cell proliferation and invasion by targeting FoxQ1, reducing epithelial-mesenchymal transition (EMT).
Area of Science:
- Molecular Oncology
- Cancer Biology
- MicroRNA Research
Background:
- Gastric cancer is a significant global health concern with complex molecular underpinnings.
- MicroRNAs play crucial roles in cancer development and progression, acting as potential therapeutic targets.
- The specific role of microRNA-96-5p (miRNA-96-5p) in gastric cancer pathogenesis requires further elucidation.
Purpose of the Study:
- To investigate the functional role of miRNA-96-5p in gastric cancer cell proliferation and invasion.
- To elucidate the molecular mechanism by which miRNA-96-5p exerts its effects in gastric cancer.
- To determine the relationship between miRNA-96-5p and forkhead box Q1 (FoxQ1) expression in gastric cancer.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) and immunohistochemistry (IHC) were used to assess miRNA-96-5p and FoxQ1 expression in gastric cancer tissues and cell lines.
- Gastric cancer cells (BGC-823) were transfected with miRNA-96-5p mimics to evaluate its effects on proliferation (CCK-8 assay) and invasion (Transwell assay).
- Western blot analysis was performed to measure protein levels of FoxQ1, E-cadherin, and vimentin. Dual-luciferase reporter assays confirmed the direct interaction between miRNA-96-5p and FoxQ1.
Main Results:
- miRNA-96-5p expression was significantly lower in gastric cancer tissues compared to adjacent normal tissues.
- FoxQ1 expression was significantly higher in gastric cancer tissues and negatively correlated with miRNA-96-5p levels.
- Overexpression of miRNA-96-5p suppressed gastric cancer cell proliferation and invasion, reduced FoxQ1 protein levels, upregulated E-cadherin, and downregulated vimentin, indicating inhibition of epithelial-mesenchymal transition (EMT).
Conclusions:
- miRNA-96-5p acts as a tumor suppressor in gastric cancer.
- miRNA-96-5p inhibits gastric cancer cell proliferation, invasion, and EMT by downregulating the expression of FoxQ1.
- These findings highlight miRNA-96-5p as a potential therapeutic target for gastric cancer treatment.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cell Migration
Cell Migration
Feedback Inhibition
Cells Coordinate Growth and Proliferation

